
DOJ's Dengvaxia Decision Draws Fire Conflict of Interest Concerns Emerge This title effectively captures the main topic of the blog post, which is the controversy surrounding the Department of Justice's (DOJ) decision to dismiss 98 cases related to the anti-dengue vaccine Dengvaxia. The use of Draws Fire suggests that there is strong opposition or criticism towards the DOJ's decision, while Conflict of Interest Concerns Emerge highlights the potential issue at hand. Overall, the title is informative, attention-grabbing, and relevant to the content of the blog post.
DOJ's Dengvaxia Decision Draws Fire Conflict of Interest Concerns Emerge This title effectively captures the main topic of the blog post, which is the controversy surrounding the Department of Justice's (DOJ) decision to dismiss 98 cases related to the anti-dengue vaccine Dengvaxia. The use of Draws Fire suggests that there is strong opposition or criticism towards the DOJ's decision, while Conflict of Interest Concerns Emerge highlights the potential issue at hand. Overall, the title is informative, attention-grabbing, and relevant to the content of the blog post.
Title DOJ's Dengvaxia Decision Draws Fire Conflict of Interest Concerns Emerge
The Department of Justice (DOJ) has faced intense scrutiny over its decision to dismiss 98 cases related to the anti-dengue vaccine Dengvaxia. Dr. Anthony Leachon, a health reform advocate and former special adviser for non-communicable diseases at the Department of Health (DOH), has slammed the decision as deplorable and raised concerns about a potential conflict of interest.
The cases in question involve allegations of reckless imprudence resulting in homicide against former health secretary Janette Garin and two others. Dr. Leachon has cited obvious proofs that align with Sanofi Pasteur's admissions regarding fatal risks and adverse effects associated with the vaccine. He has also highlighted the alleged connection between DOJ Undersecretary Jesse Andres, a former personal lawyer of Garin, one of the accused.
As a former consultant to the National Task Force on Covid-19, Dr. Leachon emphasized that justice is being undermined by the DOJ's decision. He also drew attention to the lack of legislation addressing conflict of interest between medical professionals and the pharmaceutical industry, stating that corrupt doctors eroding the Hippocratic oath must be held accountable.
The Public Attorney's Office (PAO), which filed the complaints and has since filed a motion for reconsideration, shares Dr. Leachon's concerns. The PAO stressed that the blood of multiple victims is crying out for justice and due care.
The controversy surrounding Dengvaxia underscores the importance of ensuring that justice is served in cases involving serious allegations. As Dr. Leachon noted, it is crucial that the public be informed when a conflict of interest may influence the outcome of a case.
Keywords DOJ, Dengvaxia, conflict of interest, Sanofi Pasteur, health reform, non-communicable diseases, justice.